Effects of dapagliflozin on cardiovascular events, death, and safety outcomes in patients with heart failure: a meta-analysis

XD Zheng, Q Qu, XY Jiang, ZY Wang, C Tang… - American Journal of …, 2021 - Springer
Background Several clinical trials of dapagliflozin in patients with type 2 diabetes mellitus
(T2DM) at elevated cardiovascular risk have observed reduced hospitalization for heart …
被引用次数：14 相关文章

Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-Analysis

XD Zheng, Q Qu, XY Jiang… - … devices, and other …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Several clinical trials of dapagliflozin in patients with type 2 diabetes mellitus
(T2DM) at elevated cardiovascular risk have observed reduced hospitalization for heart …

Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-Analysis.

XD Zheng, Q Qu, XY Jiang, ZY Wang… - American Journal of …, 2020 - europepmc.org
Background Several clinical trials of dapagliflozin in patients with type 2 diabetes mellitus
(T2DM) at elevated cardiovascular risk have observed reduced hospitalization for heart …